 | • レポートコード：MRC23Q30427 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（2-3日） • 産業分類：化学＆材料 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の解熱・鎮痛剤原料市場について調査・分析し、世界の解熱・鎮痛剤原料市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、デキシブプロフェン、成長期、その他）、用途別セグメント分析（大人、小人）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED、Mallinckrodt Pharmaceuticals、IOL、Anqiu Lu'an Pharmaceutical Co., Ltd.、Basf、Novacyl、BBCA Pharmaceutical、Hubei Biocause Phamaceutical Co., Ltd.、Changshu Huagang Pharmaceutical Co., Ltd、Granules India Limited、Hebei Jiheng pharmaceutical Co., Ltd、Kangle Pharmaceutical CO., LTD、Hebei Jingye Medical Technology Co., Ltd、Hunan Zhongnan Pharmaceutical Co., Ltdなどが含まれています。 世界の解熱・鎮痛剤原料市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争による影響は、解熱・鎮痛剤原料市場規模を推定する際に考慮しました。本レポートは、解熱・鎮痛剤原料の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、解熱・鎮痛剤原料に関するビジネス上の意思決定に役立てることを目的としています。 ・解熱・鎮痛剤原料市場の概要 - 製品の定義 - 解熱・鎮痛剤原料のタイプ別セグメント - 世界の解熱・鎮痛剤原料市場成長率のタイプ別分析（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、デキシブプロフェン、成長期、その他） - 解熱・鎮痛剤原料の用途別セグメント - 世界の解熱・鎮痛剤原料市場成長率の用途別分析（大人、小人） - 世界市場の成長展望 - 世界の解熱・鎮痛剤原料生産量の推定と予測（2018年-2029年） - 世界の解熱・鎮痛剤原料生産能力の推定と予測（2018年-2029年） - 解熱・鎮痛剤原料の平均価格の推定と予測（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 解熱・鎮痛剤原料市場の競争状況およびトレンド ・解熱・鎮痛剤原料の地域別生産量 - 解熱・鎮痛剤原料生産量の地域別推計と予測（2018年-2029年） - 地域別解熱・鎮痛剤原料価格分析（2018年-2023年） - 北米の解熱・鎮痛剤原料生産規模（2018年-2029年） - ヨーロッパの解熱・鎮痛剤原料生産規模（2018年-2029年） - 中国の解熱・鎮痛剤原料生産規模（2018年-2029年） - 日本の解熱・鎮痛剤原料生産規模（2018年-2029年） - 韓国の解熱・鎮痛剤原料生産規模（2018年-2029年） - インドの解熱・鎮痛剤原料生産規模（2018年-2029年） ・解熱・鎮痛剤原料の地域別消費量 - 解熱・鎮痛剤原料消費量の地域別推計と予測（2018年-2029年） - 北米の解熱・鎮痛剤原料消費量（2018年-2029年） - アメリカの解熱・鎮痛剤原料消費量（2018年-2029年） - ヨーロッパの解熱・鎮痛剤原料消費量（2018年-2029年） - アジア太平洋の解熱・鎮痛剤原料消費量（2018年-2029年） - 中国の解熱・鎮痛剤原料消費量（2018年-2029年） - 日本の解熱・鎮痛剤原料消費量（2018年-2029年） - 韓国の解熱・鎮痛剤原料消費量（2018年-2029年） - 東南アジアの解熱・鎮痛剤原料消費量（2018年-2029年） - インドの解熱・鎮痛剤原料消費量（2018年-2029年） - 中南米・中東・アフリカの解熱・鎮痛剤原料消費量（2018年-2029年） ・タイプ別セグメント：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプジン、デキシブプロフェン、成長期、その他 - 世界の解熱・鎮痛剤原料のタイプ別生産量（2018年-2023年） - 世界の解熱・鎮痛剤原料のタイプ別生産量（2024年-2029年） - 世界の解熱・鎮痛剤原料のタイプ別価格 ・用途別セグメント：大人、小人 - 世界の解熱・鎮痛剤原料の用途別生産量（2018年-2023年） - 世界の解熱・鎮痛剤原料の用途別生産量（2024年-2029年） - 世界の解熱・鎮痛剤原料の用途別価格 ・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED、Mallinckrodt Pharmaceuticals、IOL、Anqiu Lu'an Pharmaceutical Co., Ltd.、Basf、Novacyl、BBCA Pharmaceutical、Hubei Biocause Phamaceutical Co., Ltd.、Changshu Huagang Pharmaceutical Co., Ltd、Granules India Limited、Hebei Jiheng pharmaceutical Co., Ltd、Kangle Pharmaceutical CO., LTD、Hebei Jingye Medical Technology Co., Ltd、Hunan Zhongnan Pharmaceutical Co., Ltd ・産業チェーンと販売チャネルの分析 - 解熱・鎮痛剤原料産業チェーン分析 - 解熱・鎮痛剤原料の主要原材料 - 解熱・鎮痛剤原料の販売チャネル - 解熱・鎮痛剤原料のディストリビューター - 解熱・鎮痛剤原料の主要顧客 ・解熱・鎮痛剤原料市場ダイナミクス - 解熱・鎮痛剤原料の業界動向 - 解熱・鎮痛剤原料市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Antipyretic and Analgesic Raw Materials market was valued at US$ 2711.5 million in 2022 and is anticipated to reach US$ 3129.7 million by 2029, witnessing a CAGR of 1.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Shandong Xinhua Pharmaceutical Company Limited and Mallinckrodt Pharmaceuticals are the top 2 manufacturers of antipyretic and analgesic raw materials globally and holds over 30% of global market share in total. Geographically speaking, North America holds about 25% of total market share, followed by China with over 20% share. In terms of type, paracetamol segment holds over half of total market share, followed by ibuprofen with over 20% share. In terms of end users, adult segment holds a dominant share of over 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antipyretic and Analgesic Raw Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic and Analgesic Raw Materials.
The Antipyretic and Analgesic Raw Materials market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antipyretic and Analgesic Raw Materials market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipyretic and Analgesic Raw Materials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu’an Pharmaceutical Co., Ltd.
Basf
Novacyl
BBCA Pharmaceutical
Hubei Biocause Phamaceutical Co., Ltd.
Changshu Huagang Pharmaceutical Co., Ltd
Granules India Limited
Hebei Jiheng pharmaceutical Co., Ltd
Kangle Pharmaceutical CO., LTD
Hebei Jingye Medical Technology Co., Ltd
Hunan Zhongnan Pharmaceutical Co., Ltd
Segment by Type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxapzin
Dexibuprofen
Anagen
Others
Segment by Application
Adult
Child
Production by Region
North America
Europe
China
Japan
India
Southeast Asia
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antipyretic and Analgesic Raw Materials manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Antipyretic and Analgesic Raw Materials by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Antipyretic and Analgesic Raw Materials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Antipyretic and Analgesic Raw Materials Market Overview
1.1 Product Definition
1.2 Antipyretic and Analgesic Raw Materials Segment by Type
1.2.1 Global Antipyretic and Analgesic Raw Materials Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxapzin
1.2.8 Dexibuprofen
1.2.9 Anagen
1.2.10 Others
1.3 Antipyretic and Analgesic Raw Materials Segment by Application
1.3.1 Global Antipyretic and Analgesic Raw Materials Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Adult
1.3.3 Child
1.4 Global Market Growth Prospects
1.4.1 Global Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Antipyretic and Analgesic Raw Materials Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Antipyretic and Analgesic Raw Materials Production Estimates and Forecasts (2018-2029)
1.4.4 Global Antipyretic and Analgesic Raw Materials Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Antipyretic and Analgesic Raw Materials Production Market Share by Manufacturers (2018-2023)
2.2 Global Antipyretic and Analgesic Raw Materials Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Antipyretic and Analgesic Raw Materials, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Antipyretic and Analgesic Raw Materials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Antipyretic and Analgesic Raw Materials Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Antipyretic and Analgesic Raw Materials, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Antipyretic and Analgesic Raw Materials, Product Offered and Application
2.8 Global Key Manufacturers of Antipyretic and Analgesic Raw Materials, Date of Enter into This Industry
2.9 Antipyretic and Analgesic Raw Materials Market Competitive Situation and Trends
2.9.1 Antipyretic and Analgesic Raw Materials Market Concentration Rate
2.9.2 Global 5 and 10 Largest Antipyretic and Analgesic Raw Materials Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Antipyretic and Analgesic Raw Materials Production by Region
3.1 Global Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Antipyretic and Analgesic Raw Materials Production Value by Region (2018-2029)
3.2.1 Global Antipyretic and Analgesic Raw Materials Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Antipyretic and Analgesic Raw Materials by Region (2024-2029)
3.3 Global Antipyretic and Analgesic Raw Materials Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Antipyretic and Analgesic Raw Materials Production by Region (2018-2029)
3.4.1 Global Antipyretic and Analgesic Raw Materials Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Antipyretic and Analgesic Raw Materials by Region (2024-2029)
3.5 Global Antipyretic and Analgesic Raw Materials Market Price Analysis by Region (2018-2023)
3.6 Global Antipyretic and Analgesic Raw Materials Production and Value, Year-over-Year Growth
3.6.1 North America Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts (2018-2029)
3.6.5 India Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts (2018-2029)
3.6.6 Southeast Asia Antipyretic and Analgesic Raw Materials Production Value Estimates and Forecasts (2018-2029)
4 Antipyretic and Analgesic Raw Materials Consumption by Region
4.1 Global Antipyretic and Analgesic Raw Materials Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Antipyretic and Analgesic Raw Materials Consumption by Region (2018-2029)
4.2.1 Global Antipyretic and Analgesic Raw Materials Consumption by Region (2018-2023)
4.2.2 Global Antipyretic and Analgesic Raw Materials Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Antipyretic and Analgesic Raw Materials Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Antipyretic and Analgesic Raw Materials Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Antipyretic and Analgesic Raw Materials Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Antipyretic and Analgesic Raw Materials Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Antipyretic and Analgesic Raw Materials Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Antipyretic and Analgesic Raw Materials Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Antipyretic and Analgesic Raw Materials Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Antipyretic and Analgesic Raw Materials Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Antipyretic and Analgesic Raw Materials Production by Type (2018-2029)
5.1.1 Global Antipyretic and Analgesic Raw Materials Production by Type (2018-2023)
5.1.2 Global Antipyretic and Analgesic Raw Materials Production by Type (2024-2029)
5.1.3 Global Antipyretic and Analgesic Raw Materials Production Market Share by Type (2018-2029)
5.2 Global Antipyretic and Analgesic Raw Materials Production Value by Type (2018-2029)
5.2.1 Global Antipyretic and Analgesic Raw Materials Production Value by Type (2018-2023)
5.2.2 Global Antipyretic and Analgesic Raw Materials Production Value by Type (2024-2029)
5.2.3 Global Antipyretic and Analgesic Raw Materials Production Value Market Share by Type (2018-2029)
5.3 Global Antipyretic and Analgesic Raw Materials Price by Type (2018-2029)
6 Segment by Application
6.1 Global Antipyretic and Analgesic Raw Materials Production by Application (2018-2029)
6.1.1 Global Antipyretic and Analgesic Raw Materials Production by Application (2018-2023)
6.1.2 Global Antipyretic and Analgesic Raw Materials Production by Application (2024-2029)
6.1.3 Global Antipyretic and Analgesic Raw Materials Production Market Share by Application (2018-2029)
6.2 Global Antipyretic and Analgesic Raw Materials Production Value by Application (2018-2029)
6.2.1 Global Antipyretic and Analgesic Raw Materials Production Value by Application (2018-2023)
6.2.2 Global Antipyretic and Analgesic Raw Materials Production Value by Application (2024-2029)
6.2.3 Global Antipyretic and Analgesic Raw Materials Production Value Market Share by Application (2018-2029)
6.3 Global Antipyretic and Analgesic Raw Materials Price by Application (2018-2029)
7 Key Companies Profiled
7.1 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED
7.1.1 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED Antipyretic and Analgesic Raw Materials Corporation Information
7.1.2 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED Antipyretic and Analgesic Raw Materials Product Portfolio
7.1.3 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.1.4 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED Main Business and Markets Served
7.1.5 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED Recent Developments/Updates
7.2 Mallinckrodt Pharmaceuticals
7.2.1 Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Raw Materials Corporation Information
7.2.2 Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Raw Materials Product Portfolio
7.2.3 Mallinckrodt Pharmaceuticals Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.3 IOL
7.3.1 IOL Antipyretic and Analgesic Raw Materials Corporation Information
7.3.2 IOL Antipyretic and Analgesic Raw Materials Product Portfolio
7.3.3 IOL Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.3.4 IOL Main Business and Markets Served
7.3.5 IOL Recent Developments/Updates
7.4 Anqiu Lu’an Pharmaceutical Co., Ltd.
7.4.1 Anqiu Lu’an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Raw Materials Corporation Information
7.4.2 Anqiu Lu’an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Raw Materials Product Portfolio
7.4.3 Anqiu Lu’an Pharmaceutical Co., Ltd. Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Anqiu Lu’an Pharmaceutical Co., Ltd. Main Business and Markets Served
7.4.5 Anqiu Lu’an Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5 Basf
7.5.1 Basf Antipyretic and Analgesic Raw Materials Corporation Information
7.5.2 Basf Antipyretic and Analgesic Raw Materials Product Portfolio
7.5.3 Basf Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Basf Main Business and Markets Served
7.5.5 Basf Recent Developments/Updates
7.6 Novacyl
7.6.1 Novacyl Antipyretic and Analgesic Raw Materials Corporation Information
7.6.2 Novacyl Antipyretic and Analgesic Raw Materials Product Portfolio
7.6.3 Novacyl Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Novacyl Main Business and Markets Served
7.6.5 Novacyl Recent Developments/Updates
7.7 BBCA Pharmaceutical
7.7.1 BBCA Pharmaceutical Antipyretic and Analgesic Raw Materials Corporation Information
7.7.2 BBCA Pharmaceutical Antipyretic and Analgesic Raw Materials Product Portfolio
7.7.3 BBCA Pharmaceutical Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.7.4 BBCA Pharmaceutical Main Business and Markets Served
7.7.5 BBCA Pharmaceutical Recent Developments/Updates
7.8 Hubei Biocause Phamaceutical Co., Ltd.
7.8.1 Hubei Biocause Phamaceutical Co., Ltd. Antipyretic and Analgesic Raw Materials Corporation Information
7.8.2 Hubei Biocause Phamaceutical Co., Ltd. Antipyretic and Analgesic Raw Materials Product Portfolio
7.8.3 Hubei Biocause Phamaceutical Co., Ltd. Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Hubei Biocause Phamaceutical Co., Ltd. Main Business and Markets Served
7.7.5 Hubei Biocause Phamaceutical Co., Ltd. Recent Developments/Updates
7.9 Changshu Huagang Pharmaceutical Co., Ltd
7.9.1 Changshu Huagang Pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Corporation Information
7.9.2 Changshu Huagang Pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Product Portfolio
7.9.3 Changshu Huagang Pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Changshu Huagang Pharmaceutical Co., Ltd Main Business and Markets Served
7.9.5 Changshu Huagang Pharmaceutical Co., Ltd Recent Developments/Updates
7.10 Granules India Limited
7.10.1 Granules India Limited Antipyretic and Analgesic Raw Materials Corporation Information
7.10.2 Granules India Limited Antipyretic and Analgesic Raw Materials Product Portfolio
7.10.3 Granules India Limited Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Granules India Limited Main Business and Markets Served
7.10.5 Granules India Limited Recent Developments/Updates
7.11 Hebei Jiheng pharmaceutical Co., Ltd
7.11.1 Hebei Jiheng pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Corporation Information
7.11.2 Hebei Jiheng pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Product Portfolio
7.11.3 Hebei Jiheng pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Hebei Jiheng pharmaceutical Co., Ltd Main Business and Markets Served
7.11.5 Hebei Jiheng pharmaceutical Co., Ltd Recent Developments/Updates
7.12 Kangle Pharmaceutical CO., LTD
7.12.1 Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Raw Materials Corporation Information
7.12.2 Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Raw Materials Product Portfolio
7.12.3 Kangle Pharmaceutical CO., LTD Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Kangle Pharmaceutical CO., LTD Main Business and Markets Served
7.12.5 Kangle Pharmaceutical CO., LTD Recent Developments/Updates
7.13 Hebei Jingye Medical Technology Co., Ltd
7.13.1 Hebei Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Raw Materials Corporation Information
7.13.2 Hebei Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Raw Materials Product Portfolio
7.13.3 Hebei Jingye Medical Technology Co., Ltd Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Hebei Jingye Medical Technology Co., Ltd Main Business and Markets Served
7.13.5 Hebei Jingye Medical Technology Co., Ltd Recent Developments/Updates
7.14 Hunan Zhongnan Pharmaceutical Co., Ltd
7.14.1 Hunan Zhongnan Pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Corporation Information
7.14.2 Hunan Zhongnan Pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Product Portfolio
7.14.3 Hunan Zhongnan Pharmaceutical Co., Ltd Antipyretic and Analgesic Raw Materials Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Hunan Zhongnan Pharmaceutical Co., Ltd Main Business and Markets Served
7.14.5 Hunan Zhongnan Pharmaceutical Co., Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Antipyretic and Analgesic Raw Materials Industry Chain Analysis
8.2 Antipyretic and Analgesic Raw Materials Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Antipyretic and Analgesic Raw Materials Production Mode & Process
8.4 Antipyretic and Analgesic Raw Materials Sales and Marketing
8.4.1 Antipyretic and Analgesic Raw Materials Sales Channels
8.4.2 Antipyretic and Analgesic Raw Materials Distributors
8.5 Antipyretic and Analgesic Raw Materials Customers
9 Antipyretic and Analgesic Raw Materials Market Dynamics
9.1 Antipyretic and Analgesic Raw Materials Industry Trends
9.2 Antipyretic and Analgesic Raw Materials Market Drivers
9.3 Antipyretic and Analgesic Raw Materials Market Challenges
9.4 Antipyretic and Analgesic Raw Materials Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer